Inside-out cells offer target for antiviral drugs <:3

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Inside-out cells offer target for antiviral drugs <:3

Postby rainer » Mon Nov 24, 2008 8:04 pm

Inside-out cells offer target for antiviral drugs

CHICAGO (Reuters) - An experimental drug cured guinea pigs infected with a fatal hemorrhagic fever virus, raising hope for its use in a broad range of viral diseases including influenza, hepatitis C, HIV, Ebola and others, U.S. researchers said on Sunday.

"This is a whole new strategy for making antiviral drugs," said Dr. Philip Thorpe, professor of pharmacology at the University of Texas Southwestern Medical Center at Dallas, whose research appears in the journal Nature Medicine.

Instead of attacking the virus directly, bavituximab, made by Peregrine Pharmaceuticals Inc, takes advantage of a defense mechanism used by the virus to hide from the immune system, Thorpe said.

When cells are under attack by a virus, this stress causes a fat molecule called phosphatidylserine, which normally lines the inside of the cell, to flip to the outside. "It's like wearing your clothes inside out," Thorpe, a scientific adviser to Peregrine, said in a telephone interview.

Bavituximab, a genetically engineered antibody, seeks out and attaches itself to these turncoat cells, flagging them for the immune system, which can then mount an attack,

"When injected into the bloodstream, bavituximab circulates in the body until it finds these inside-out lipids and then binds to them," Thorpe said in a statement.

"In the case of virus infection, the binding raises a red flag to the body's immune system, forcing the deployment of defensive white blood cells to attack the infected cells."

Thorpe said conventional antiviral drugs try to exploit some property of the virus, but these drugs are often quickly defeated as the virus mutates.

By targeting an aspect of infected cells in the host, he thinks bavituximab is less likely to lose effectiveness, which commonly happens when a virus mutates.

In the study, Thorpe and his colleagues tested the compound on guinea pigs in an advanced stage of infection with a form of the Lassa fever virus, a disease that affects parts of West Africa.

Half of the animals treated with the drug alone were cured. When the researchers tested it in combination with the antiviral drug ribavirin, a drug that keeps a virus from replicating, 63 percent of the guinea pigs lived.

Thorpe said the findings suggest the drug might be effective on other types of hemorrhagic viruses, such as Ebola and Marburg. But this lipid flipping also occurs in cells infected with many other viral infections, including influenza, smallpox and rabies.

Peregrine is conducting early phase clinical trials of the drug in people with hepatitis C and human immunodeficiency virus, or HIV, which causes AIDS. And it has more advanced trials under way in cancer.

"We think it has tremendous potential," Steven King, president and chief executive of Peregrine, said in a telephone interview. Peregrine funded the research along with the National Institutes of Health.[/url]
User avatar
rainer
Family Elder
 
Posts: 367
Joined: Thu Jan 17, 2008 3:00 pm

Advertisement

Re: Inside-out cells offer target for antiviral drugs <:3

Postby cheerleader » Mon Dec 01, 2008 12:04 pm

rainer wrote:Inside-out cells offer target for antiviral drugs

Instead of attacking the virus directly, bavituximab, made by Peregrine Pharmaceuticals Inc, takes advantage of a defense mechanism used by the virus to hide from the immune system, Thorpe said.

When cells are under attack by a virus, this stress causes a fat molecule called phosphatidylserine, which normally lines the inside of the cell, to flip to the outside. "It's like wearing your clothes inside out," Thorpe, a scientific adviser to Peregrine, said in a telephone interview.


Thanks for this, Rainer. Interesting...sounds like the virus, cloaked in phosphatidylserine, becomes a molecular mimic for myelin, which would explain alot.

Phospholipids are a major component of all cell membranes, including those of our brain. Ofthe four classes of phospholipids, phosphatidylerine (PS) is most concentrated in the brain, where it contributes greatly to cognitive function by, among other things, stimulating neurotransmitter release. Unfortunately, aging causes a natural decline in PS throughout the body, and the effects of its decrease are especially noticeable in brain functioning.


Would be nice to kill the virus, and spare the myelin from further attack, eh?
AC
Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
http://ccsviinms.blogspot.com
User avatar
cheerleader
Family Elder
 
Posts: 5069
Joined: Mon Sep 10, 2007 2:00 pm
Location: southern California


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service